1. RETRACTED: Triptolide inhibits the growth and migration of colon carcinoma cells by down-regulation of miR-191
   Yuxi Qi et al, 2019, Experimental and Molecular Pathology CrossRef
2. Particulate matter 2.5 triggers airway inflammation and bronchial hyperresponsiveness in mice by activating the SIRT2-p65 pathway
   Manling Liu et al, 2021, Frontiers of Medicine CrossRef
3. Triptolide inhibits migration and proliferation of fibroblasts from ileocolonic anastomosis of patients with Crohn's disease via regulating the miR‑16‑1/HSP70 pathway
   Min Chen et al, 2019, Molecular Medicine Reports CrossRef
4. Inflammatory Bowel Diseases: An Updated Overview on the Heat Shock Protein Involvement
   Federica Scalia et al, 2023, International Journal of Molecular Sciences CrossRef
5. A comprehensive review of Tripterygium wilfordii hook. f. in the treatment of rheumatic and autoimmune diseases: Bioactive compounds, mechanisms of action, and future directions
   Yu Shan et al, 2023, Frontiers in Pharmacology CrossRef
6. Neuroprotective effect of triptolide on neuronal inflammation in rats with mild brain injury
   Zhanglu Fang et al, 2024, IBRO Neuroscience Reports CrossRef
7. Impact of the Exposome on the Epigenome in Inflammatory Bowel Disease Patients and Animal Models
   Sophie Vieujean et al, 2022, International Journal of Molecular Sciences CrossRef
8. Triptolide Modulates the Expression of Inflammation-Associated lncRNA-PACER and lincRNA-p21 in Mycobacterium tuberculosis–Infected Monocyte-Derived Macrophages
   Ousman Tamgue et al, 2021, Frontiers in Pharmacology CrossRef
9. Research Progress of Triptolide Against Fibrosis
   Minmin Jiang et al, 2024, Drug Design, Development and Therapy CrossRef
10. Functions and targets of miRNAs in pharmacological and toxicological effects of major components of Tripterygium wilfordii Hook F
    Wei Pan et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
11. Traditional Chinese Medicine: A Promising Treatment Option for Intestinal Fibrosis
    Meng’en Zhou et al, 2024, The American Journal of Chinese Medicine CrossRef
12. MiRNA-Based Therapies for the Treatment of Inflammatory Bowel Disease: What Are We Still Missing?
    Tommaso Innocenti et al, 2023, Inflammatory Bowel Diseases CrossRef
13. Tripterygium hypoglaucum (Levl.) Hutch: A systematic review of its traditional uses, botany, phytochemistry, pharmacology, pharmacokinetics and toxicology
    Jiangping Wei et al, 2022, Pharmacological Research - Modern Chinese Medicine CrossRef
14. Noncoding RNAs as Promising Diagnostic Biomarkers and Therapeutic Targets in Intestinal Fibrosis of Crohn’s Disease: The Path From Bench to Bedside
    Long-Yuan Zhou et al, 2021, Inflammatory Bowel Diseases CrossRef